Statistics for An exploratory study of sunitinib plus paclitaxel as first-line treatment for patients with advanced breast cancer
Total visits
| views | |
|---|---|
| An exploratory study of sunitinib plus paclitaxel as first-line treatment for patients with advanced breast cancer | 118 |
Total visits per month
| views | |
|---|---|
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
File Visits
| views | |
|---|---|
| PIIS0923753419394803.pdf | 108 |
| java.util.UUID:ecfb2817-1407-4931-b8ce-e10194d5461e | 34 |
| java.util.UUID:6529a055-90f3-426e-bb8d-402490861ed2 | 9 |
| java.util.UUID:6c488c77-4dc9-4729-94a2-cd93c90dca78 | 4 |
Top country views
| views | |
|---|---|
| United States | 96 |
| Germany | 3 |
| Canada | 2 |
| China | 2 |
| Sweden | 2 |
| Ukraine | 2 |
| Vietnam | 2 |
| United Kingdom | 1 |
| Lebanon | 1 |
| Malaysia | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 42 |
| Fairfield | 13 |
| Houston | 11 |
| Cambridge | 4 |
| Jacksonville | 4 |
| Kiez | 3 |
| Dong Ket | 2 |
| Kiev | 2 |
| San Francisco | 2 |
| Toronto | 2 |
| Ann Arbor | 1 |
| Beirut | 1 |
| Irvine | 1 |
| Seattle | 1 |
| Seremban | 1 |
| Stockholm | 1 |